Gasdermin E–mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome
The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
GSDME-mediated target cell pyroptosis by CAR T cells activates macrophages to release proinflammatory cytokines for CRS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Treatment for CRS and associated neurotoxicity primarily targets IL-6, likely arising from monocytes or activated endothelium [1, 6, 11–17].”
From Immune reconstitution and clinical recovery following anti-CD28 antibody (TGN1412)-induced cytokine storm (2021) · cites this paper as [14]
In the citing paper
“Tumor lysis most likely also contributes to the cytokine storm through the induction of pyroptosis in target cells.55”
From Cytokine storm (2020) · cites this paper as [55]
Citations
Cites
Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
Shi, J., Zhao, Y., Wang, K., Shi, X., Wang, Y., Huang, H., Zhuang, Y., Cai, T., Wang, F., & Shao, F. (2015) · Nature · doi:10.1038/nature15514 · Cited by 6,659
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
Neelapu, S. S., Locke, F. L., Bartlett, N. L., Lekakis, L. J., Miklos, D. B., Jacobson, C. A., Braunschweig, I., Oluwole, O. O., Siddiqi, T., Lin, Y., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707447 · Cited by 6,030
Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia
Maude, S. L., Laetsch, T. W., Buechner, J., Rives, S., Boyer, M., Bittencourt, H., Bader, P., Verneris, M. R., Stefanski, H. E., Myers, G. D., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1709866 · Cited by 5,735
Self-citationChimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Maude, S. L., Frey, N., Shaw, P. A., Aplenc, R., Barrett, D. M., Bunin, N. J., Chew, A., Gonzalez, V. E., Zheng, Z., Lacey, S. F., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1407222 · Cited by 5,413
Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin
Wang, Y., Gao, W., Shi, X., Ding, J., Liu, W., He, H., Wang, K., & Shao, F. (2017) · Nature · doi:10.1038/nature22393 · Cited by 3,199
U.S. Department of Health and Human Services
(2006) · Encyclopedia of Sexual Behavior and the Law · doi:10.4135/9781452240107.n226 · Cited by 3,170
Pyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death
Shi, J., Gao, W., & Shao, F. (2017) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.10.004 · Cited by 3,088
Lee, D. W., Kochenderfer, J. N., Stetler-Stevenson, M., Cui, Y. K., Delbrook, C., Feldman, S. A., Fry, T. J., Orentas, R., Sabatino, M., Shah, N. N., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61403-3 · Cited by 2,898
Pore-forming activity and structural autoinhibition of the gasdermin family
Ding, J., Wang, K., Liu, W., She, Y., Sun, Q., Shi, J., Sun, H., Wang, D.-C., & Shao, F. (2016) · Nature · doi:10.1038/nature18590 · Cited by 2,771
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
Park, J. H., Rivière, I., Gonen, M., Wang, X., Sénéchal, B., Curran, K. J., Sauter, C., Wang, Y., Santomasso, B., Mead, E., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1709919 · Cited by 2,688
Cited by
Items 501–567 of 567
He, Y., Jiang, S., Cui, Y., Liang, J., Zhong, Y., Sun, Y., Moran, M. F., Huang, Z., He, G., & Mao, X. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4613653
The roles of pyroptosis in genitourinary diseases
Liu, H., Liu, H., Huang, G., Yuan, H., & Zhang, X. (2023) · International Urology and Nephrology · doi:10.1007/s11255-023-03894-6 · Cited by 1
“In 2020, it was reported that CAR-T cells activated caspase-3 by releasing granzyme B (GzmB), subsequently leading to the activation of the caspase-3/GSDME-mediated pyroptotic pathway, thus causing pyroptosis [36].”
BackgroundSelf-citationPyroptosis and its role in gynecologic cancer
Wang, W. (2024) · International Conference on Biological Engineering and Medical Science (ICBioMed) · doi:10.1117/12.3012826
“Both GSDMs cause cell membrane perforation and lead to pyroptosis [13,14].”
BackgroundPrevention of Cytokine Release Syndrome in Chimeric Antigen Receptor T-cell Therapy
Yang, R. (2023) · Highlights in Science Engineering and Technology · doi:10.54097/fd6pgk68
“Specifically, inhibition of enzymes crucial to enhancing tumor cell pyroptosis–such as Gasdermin-E (GSDME) and caspase-3–also proved to be crucial to the prevention of CRS progression [7].”
BackgroundAvaliação da morte de linfócitos induzida pela saliva de Aedes aegypti
de Assis, J. B. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2023.tde-24012024-160811
Li, S., Lu, X., Lin, X., Zhang, Y., Liu, Q., & Chen, S. (2024) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2024.105139
Self-citationMcKenzie, B., Puisségur, M.-P., Demeersseman, L., Rodriguez, F., Cini, E., Jainarayanan, A., Widdess, M. A., Staton, C. C., Chen, L., Sibaud, V., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.24.595698 · Cited by 1
TSPAN4 Regulates the Effects of Radiation-Induced Pyroptosis in Non-Small Cell Lung CancerPreprint
Zhang, Y., Wang, Q., Hu, H., Qiu, H., Sun, W., Shen, A., Yan, J., Du, Y., & Hu, B. (2024) · Research Square · doi:10.21203/rs.3.rs-4556509/v1
Self-citationGlycolytic activity following anti‐ CD19 CAR ‐T cell infusion in non‐Hodgkin lymphoma
Vallet, N., Rochelle, L. D. L., Ribeiro, M. J., Villate, A., Eloit, M., Cirée, A., Zaragoza, L., André, V., Prat, M., Hérault, O., et al. (2024) · European Journal of Clinical Investigation · doi:10.1111/eci.14342
Karimi‐Googheri, M., Gholipourmalekabadi, M., Madjd, Z., Shabani, Z., Rostami, Z., Arababadi, M. K., & Kiani, J. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-10061-2
Hong, H., Huang, Y., Yang, Z., Jiang, X., & Liu, H. (2024) · Discover Oncology · doi:10.1007/s12672-024-01579-9
“Conversely, factors released during pyroptosis by cancer cells can induce pyroptosis in macrophages, causing the release of cytokines and subsequent cytokine release syndrome [23, 35, 36].”
Considerations for nonclinical studies conducted to support the development of cellular therapies
Bolt, M. W., & Narayanan, P. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13344-2.00011-0
Pathology, prevention and management of CAR-T cell-mediated toxicities
Lulu, A. M., Mollica, P., Lee, D. W., & Bailey, S. R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-14064-8.00034-5
Nanomaterials‐Induced Pyroptosis and Immunotherapy
Chen, H., Ding, B., Lin, J., & Ma, P. (2025) · Wiley eBooks · doi:10.1002/9783527845347.ch11
Natural Killer Cells in Microbial Host Defense: Overview with a Focus on Antifungal Activity
Polyak, M. J., Mok, A. C. H., & Mody, C. H. (2025) · Springer eBooks · doi:10.1007/978-3-662-68816-8_23-1
Advances in gasdermin activation, regulation, and targeted drug development
Luo, T., & Guo, Y. R. (2025) · Acta Materia Medica · doi:10.15212/amm-2025-0014 · Cited by 1
On the Road to Safer CAR Therapy for B-Cell Lymphoma: Real-World Evidence
DaCosta-Clark, T., Kale, B. J., & Perna, F. (2025) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2025.06.009
Mechanisms of Pyroptosis and Role in Inflammatory Bowel Disease
高, 磊. (2025) · Pharmacy Information · doi:10.12677/pi.2025.144032
Zhang, Z., Wang, H., Huang, Y., Zhu, L., Wang, X., Du, Y., Zhou, G., & Zhao, Y. (2025) · International Journal of Radiation Biology · doi:10.1080/09553002.2025.2561813 · Cited by 1
“The regulatory mechanism of cell death is primarily mediated by gasdermin and caspase family members (Liu et al. 2020; Zhou et al. 2020).”
Self-citationZuo, R., & Han, M. (2025) · Clinical & Translational Oncology · doi:10.1007/s12094-025-04087-6 · Cited by 2
Li, Y.-L., Wang, G., Shu, Y.-B., Wang, B., Huang, Y., Yan, W., Yan, H.-Y., & Xie, P. (2025) · Radiation Research · doi:10.1667/rade-25-00031.1
Yang, P., Fan, L., Yuan, D., Xie, J., Luo, Y., Zeng, Q., Lin, W., Li, Z., Huang, Z., Jiang, W., et al. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.112239 · Cited by 1
Self-citationB-cell activating factor plays a critical role in CAR-T cell-associated cytokine release syndromePreprint
Fritz, C. E., Metheny, L. L., Wald, D. N., Caimi, P. F., & Parameswaran, R. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.22.689920
Gasdermin E couples mitochondrial damage to pyroptotic neurodegeneration in Parkinson’s diseasePreprint
Pan, J., Geng, L., Liu, X., Wang, Y., Fang, N., Xie, F., Shen, Y., Deng, Y., Han, Y., Li, S., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.14.694264
Xia, P., Xing, X.-D., Yang, C.-X., Liao, X.-J., Liu, F.-H., Huang, H., Zhang, C., Song, J.-W., Jiao, Y.-M., Shi, M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19905802
Xia, P., Xing, X.-D., Yang, C.-X., Liao, X.-J., Liu, F.-H., Huang, H., Zhang, C., Song, J.-W., Jiao, Y.-M., Shi, M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19905808
Ma, X., Gui, T., Yang, S., Jin, S., Qiao, J., Xie, Y., Wang, J., Ouyang, W., Song, G., Yi, X. H., et al. (2025) · MedScience · doi:10.1007/s11684-025-1176-9 · Cited by 2
Li, F., & Zheng, L. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2025.1691189 · Cited by 1
“…CAR-T cell activation, leading to IFN-g and GM-CSF release (87 – 89); subsequent macrophage/monocyte activation, producing IL-6 and IL-1 b (55, 90, 91); and ultimately endothelial dysfunction and organ injury, mediated by DAMPs (92, 93). and secondary hemophagocytic lymphohistiocytosis (sHLH) (56).”
ZIF-8 nanoparticles alleviate cytokine release syndrome
Hu, Y. B., Jiang, C., Xu, M., Hu, Z., Jiang, W., Sun, Y., Song, J., Zhang, Y., Hu, D., Qu, K., et al. (2026) · Nano Today · doi:10.1016/j.nantod.2026.102980 · Cited by 1
Self-citationZhou, Y., Wang, D., Wang, S., Zhang, C., He, L., Kang, Y., Yuan, W. P., Nguyen, A., Chen, J., Zhou, N., et al. (2026) · Cellular and Molecular Immunology · doi:10.1038/s41423-026-01390-2
“The cells used in the experiments were maintained for up to 20 passages.”
Self-citationZhao, Q., Wang, J., Yan, Z., Liu, T., Ma, L., Qian, J., Wang, Y., & Shao, R. (2026) · Pharmaceuticals · doi:10.3390/ph19020253
AIM2 inflammasome and pyroptosis biomarkers in oncology
Dahiya, R., Shqaidef, A. J., Menon, S. V., Rathore, V., Singh, S. P., Mittal, M., Thangavelu, L., Singh, N., Hajarnavis, A. M., & Almalki, W. H. (2026) · Clinica Chimica Acta · doi:10.1016/j.cca.2026.120913
Liu, X., Gao, H., & Yu, J. (2026) · Precision Clinical Medicine · doi:10.1093/pcmedi/pbag007 · Cited by 1
“…of NFAT, AP-1, and NF-κ B, driving robust proliferation and the upregulation of cytotoxic effector molecules (per-forin, granzymes) as well as pro-inflammatory cytokines (TNF-α , IFN-γ , IL-2), which together induce target cell death via pathways such as apoptosis and pyroptosis [ 35–37 ].”
The double-edged sword of pyroptosis targeting in cancer therapy
Mao, S., Lei, T., Shi, F., Xu, J., Zhuang, W., Lu, J., Dong, X., & Yang, H. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.118788 · Cited by 2
Research topics and trends of pyroptosis based on bibliometric analysis
Leng, Q., Sun, X., & Wang, P. (2026) · Experimental Cell Research · doi:10.1016/j.yexcr.2026.114999 · Cited by 1
Huang, H., Deng, A., Pan, F., Lu, Y., Chen, L., Cao, J., Tang, Q., Liu, Y., Wu, Y., Du, J., et al. (2026) · The Innovation · doi:10.1016/j.xinn.2026.101359 · Cited by 4
“178 On the other hand, excessive pyroptosis can exacerbate pathological injury, such as GSDMD-mediated cytokine storm in sepsis, which can lead to multi-organ failure.”
Self-citationWang, Y., CHEN, J., Zhang, X., Ji, Z., Zhang, N., Li, N., Zhang, X., Zhao, S., Li, C., Shi, K., et al. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04343-z · Cited by 2
“Moreover, in adoptive cell therapies such as CAR-T and CAR-NK cells, pyroptosis is triggered in target tumor cells via granzyme-mediated cleavage of GSDMB or GSDME, enhancing tumor cell killing and immune activation [93, 94].”
Self-citationWang, Y., Mei, M., Wang, J., Wei, L., Zhang, M., & Zhang, M. (2026) · Translational Oncology · doi:10.1016/j.tranon.2026.102747 · Cited by 1
“Granzyme B in NK cells can also activate non-caspase dependent pyroptosis in target cells by directly cleaving GSDME at the same site as caspase-3 [46], implying the potential regulatory ability of the pyrop-tosis on tumor immunity.”
Immunomodulation des lymphocytes Vγ9Vδ2 dans les leucémies aigües
Floch, A.-C. L. (2023) · theses.fr (ABES) · doi:10.70675/b4e332efz0a66z4c9az85eaz8eea012e9839
Ding, C., Wu, J. I. A. H. U. I., Xu, Z., Zhang, C., Ou, C., Chen, W., Wei, H., Deng, Z., Li, Z., Long, L., et al. (2026) · Cancer Research · doi:10.1158/0008-5472.can-25-0786 · Cited by 1
Self-citationFluvoxamine Exerts Anti-influenza A Virus Effects through Inhibiting Apoptosis Pathway
Zhang, Z., Liang, H., Ren, L., & Wei, Z. (2026) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b25-00792
Self-citationResearch progress and challenges in in vivo CAR-T cell therapy
HUANG, Y.-F., & Zhang, Y. (2026) · Shengming kexue · doi:10.3724/cbls.2026074
Self-citationYu, P., Xiang, S., Hao, L., Hsu, J. C., Li, K., Yan, R., Zhou, M., Tang, Y., Peng, Y. K. M., Cai, W., et al. (2026) · Exploration · doi:10.1002/exp.20250737
“We found that 177 Lu can induce Gasder-min E (GSDME)-mediated pyroptosis, a form of inflammatory cell death characterized by the release of immunostimulatory molecules that amplify antitumor immunity [ 35, 36 ].”
On the structure and function of granzymes, the deadly squad of cytotoxic lymphocytes
Gardeazábal-Torbado, J. L., Estébanez‐Perpiñá, E., & Fuentes‐Prior, P. (2026) · Biological Chemistry · doi:10.1515/hsz-2025-0251
“However, clinical implementation requires balancing these therapeutic bene fi ts against potential increases in in fl ammatory toxicity such as cytokine release syndrome, which can be signi fi cantly ampli fi ed by mechanisms like gasdermin-mediated pyroptosis (Liu et al. 2020).”
Kanjani, V. G., Bharadia, A. A., & Morakhia, K. R. (2026) · Regenerative medicine reports . · doi:10.4103/regenmed.regenmed-d-26-00003
Schreiber, D., Peer, S., Lutz‐Nicoladoni, C., Koutník, J., Lang, V., Wille, V., Hölzl, I., Humer, D., Tokic, N., Freimark, D., et al. (2026) · Cells · doi:10.3390/cells15151407 · Cited by 1
“The cleaved N-terminal GSDME fragment (p30) is the executor of pyroptosis, forming membrane pores that cause inflammatory lytic cell death [22,29].”
Ning, S., Xing, X., Chang, Y., Mao, M., Xu, H., Ma, Y., Liang, G., Sun, X., & Liang, G. (2026) · Macromolecular Rapid Communications · doi:10.1002/marc.70400
Pyroptosis‐Inducing Nanomedicine for Cancer Immunotherapy: Mechanisms and Emerging Strategies
Wang, P., Sun, X., Yang, Y., Zhang, S., He, Z., Wang, Y., & Luo, C. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.71578
“GzmB rapidly activates caspase‑3 in target cells, which subsequently cleaves GSDME to generate its pore‑forming N‑terminal fragment (GSDME‑NT) and subsequent pyroptosis [73].”
Targeting pyroptosis for skeletal muscle atrophy: mechanistic insights and therapeutic perspectives
Sun, C., Peng, T.-J., Zhang, P., Fan, X.-L., Lu, C.-T., Jiang, H.-L., & Tang, C.-F. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1896679
“In 2020, research further identi fi ed a novel pyroptosis pathway triggered by lymphocyte toxin granzyme B, directly cleaving gasdermin proteins (GSDMB/E), expanding understanding of their role in adaptive immunity (18).”
Shi, Y., Li, T., Li, X., & Wang, F. (2026) · Tissue and Cell · doi:10.1016/j.tice.2026.103896
Yu, Z., Zhao, Z., Tian, Y., Xue, G., Wang, J., Li, Y., & Fan, H. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1904376
“Early studies showed that granzyme B (GrB) can indirectly cleave GSDME by activating caspase-3 (106).”
Xu, Q., Sun, W., Li, L., Liu, N., & Liu, B. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1901368
“Additionally, GZMA can directly cleave GSDME to trigger caspase-dependent pyroptosis in target cells (Liu et al., 2020).”
Tsurkan, A. M., Shpakova, D. V., & Ti, U. (2026) · Medicine and Biotechnology · doi:10.15507/3034-6231.26023.269-293 · Cited by 1
Shi, K., Sun, X., & Wang, G. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.117465
Liu, B. C., Poudel, S., Zhang, X., Chen, J., Tran, Q., Guy, C. S., Yang, M., Mulder, H. L., Ma, X., & Green, D. R. (2026) · Science Advances · doi:10.1126/sciadv.aeb1137
“GSDME, due to its pore-forming mechanism of action, had been postulated to both be promising for inducing tumor immunogenicity and being a risk factor for therapy-induced adverse events ( 33 , 68 ).”
Self-citationThe gasdermin family: from pyroptosis mechanisms to therapeutic targets
Xu, W., Liu, S., Yu, Z., Shi, J., Yang, Y., & Shi, F. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02867-2
“…by cytotoxic T lymphocytes (CTLs) that typically initiate apoptosis, have also been found to directly process and activate GSDMB and GSDME and trigger pyroptosis in cells expressing these speci fi c GSDMs. 25,256 The absence of key pyroptosis mediators can also shift the pathway toward apoptosis.”
Chemokines as regulators of CAR-T cell trafficking, function, and context-dependent tumor cell death
Levchuk, K., Petukhov, A., Tursymbek, S., Seitkamal, K., Bertleuova, A., Bulanin, D., & Barlev, N. A. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1963794
“Separately, Liu et al. showed that granzyme B secreted by CAR-T cells activated caspase-3 in tumor cells, which subsequently triggered GSDME-dependent pyroptosis (116).”
CAR-T Cell Therapy: Structure, Mechanism of Action, Adverse Effects, and Current Challenges
Prajapati, K. K., & Tripathi, P. (2026) · British Journal of Contemporary Research · doi:10.67693/bjcr-cwllxlwq
Pyroptosis in myocardial ischemia-reperfusion injury: mechanistic pathways and therapeutic prospects
Ding, S., Zhang, X., Sheng, Z., Wang, Y., & 方, 五. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1938791
“The damage signals released during pyroptosis then further activate the canonical caspase-1/GSDMD pyroptotic pathway in macrophages (Liu et al., 2020).”
Self-citationAntonov, D., Loguinova, M. Y., Fan, H., Sazonova, E. V., Sosnovtseva, A. O., Karpov, D. S., Molchanov, A. D., Nikolenko, V. N., Chekhonin, V. P., & Mokrysheva, N. G. (2026) · Cells · doi:10.3390/cells15201902
Kuligina, E. S., Yanus, G. A., & Имянитов, Е. Н. (2026) · Biochemistry (Moscow) · doi:10.1134/s0006297926603096
“The resulting activation of macrophages through GSDMD subsequently induces the massive release of proinflammatory mediators and contributes to the development of cytokine release syndrome [166].”
BindingDB (2024) · UC San Diego · doi:10.7270/q2t72nnm
Li, J., Wang, Z., Zhu, D., Gao, H., & Wang, J. (2026) · Biomolecules · doi:10.3390/biom16111577
Self-citation
Metadata
- Authors
- Liu, Y., Fang, Y., Chen, X., Wang, Z., Liang, X., Zhang, T., Liu, M., Zhou, N., Lv, J., Tang, K., Xie, J., Gao, Y., Cheng, F., Zhou, Y., Zhang, Z., Hu, Y., Zhang, X., Gao, Q., Zhang, Y., & Huang, B.
- Affiliations
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- First Affiliated Hospital of Zhengzhou University (CN)
- Huazhong University of Science and Technology (CN)
- Wuhan Union Hospital (CN)
- Peking University People's Hospital (CN)
- Zhengzhou University (CN)
- Corresponding author
- Liu, Yuying
- Fang, Yiliang
- Chen, Xinfeng
- Huang, Bo
- ORCID
- Venue
- Science Immunology
- Published
- 2020-01-03
- Volume
- 5
- Issue
- 43
- ISSN
- 2470-9468 (ISSN-L)
- OpenAlex
- W2999534343
- Cited by
- 566
- References
- 45
- Citations by year
- 2026: 63 · 2025: 87 · 2024: 100 · 2023: 127 · 2022: 96 · 2021: 70 · 2020: 22
- FWCI
- 28.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81788101, 81661128007, 81530080, 81773062)
- Topics
- Health Sciences › Medicine › Oncology › CAR-T cell therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- gasdermin E, pyroptosis, chimeric antigen receptor T cells, cytokine release syndrome, macrophage activation, inflammatory cytokines, target cell death, adoptive T cell therapy
- MeSH terms
- Pyroptosis, Cytokine Release Syndrome, Gasdermins, Animals, Female, Humans, Macrophages, T-Lymphocytes, Leukemia, B-Cell, Immunotherapy, Adoptive, Phosphate-Binding Proteins, Cell Line, Tumor, Intracellular Signaling Peptides and Proteins, Mice, Granzymes, Perforin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.